Hydrochlorothiazide & Pulmonary Edema: A Case Report

by Grace Chen

BOSTON, December 29, 2025 — A seemingly harmless diuretic, hydrochlorothiazide, commonly prescribed for high blood pressure, sent a 68-year-old Massachusetts man to the emergency room with a surprising and potentially life-threatening complication: pulmonary edema. The case, detailed in a recent report, underscores the importance of vigilance even with well-established medications.

Unexpected Fluid Buildup Linked to Common Blood Pressure Drug

Pulmonary edema, fluid in the lungs, is a serious condition that can cause shortness of breath and respiratory failure.

  • Hydrochlorothiazide, a widely used diuretic, can rarely cause pulmonary edema.
  • The condition developed in a 68-year-old man after several months of consistent use.
  • Early recognition and prompt treatment are crucial for managing hydrochlorothiazide-induced pulmonary edema.
  • Healthcare providers should consider this rare side effect when evaluating patients on this medication.

Hydrochlorothiazide-induced pulmonary edema is an uncommon, yet documented, adverse reaction to the medication. The primary keyword, hydrochlorothiazide, is a thiazide diuretic frequently used to treat hypertension and edema, but this case highlights a paradoxical effect.

Can a diuretic *cause* fluid buildup in the lungs? Yes, though rarely. In this instance, the mechanism isn’t fully understood, but it’s thought to involve a non-cardiogenic pulmonary edema—meaning the fluid isn’t due to heart failure, but rather a direct effect of the drug on the lungs.

Patient Presentation and Diagnosis

The patient, with a history of hypertension, had been taking hydrochlorothiazide 25 mg daily for approximately three months when he presented to the emergency department with progressively worsening shortness of breath. Initial assessment revealed bilateral crackles in his lungs, indicative of fluid accumulation. Chest X-rays confirmed the presence of pulmonary edema. Other potential causes, such as heart failure and pneumonia, were ruled out through further testing, including an electrocardiogram and blood tests.

According to the report, the patient denied any history of cardiac disease or recent respiratory infections. His symptoms began gradually and worsened over several days. The medical team immediately discontinued the hydrochlorothiazide and initiated treatment with supplemental oxygen and diuretics to remove the excess fluid from his lungs. His condition improved significantly within 48 hours of treatment.

The Puzzle of Paradoxical Edema

The case presents a diagnostic challenge, as diuretics are typically used to *treat* fluid overload. The authors emphasize the importance of considering drug-induced pulmonary edema in patients presenting with unexplained respiratory distress, particularly those taking hydrochlorothiazide. “This case serves as a reminder that even commonly prescribed medications can have rare but serious side effects,” the report stated.

The exact mechanism behind hydrochlorothiazide-induced pulmonary edema remains unclear. One proposed theory suggests that the drug may alter pulmonary capillary permeability, leading to fluid leakage into the lung tissues. Another hypothesis involves an immune-mediated reaction to the medication.

Implications for Clinical Practice

While the incidence of hydrochlorothiazide-induced pulmonary edema is low, healthcare professionals should be aware of this potential adverse effect. Patients taking hydrochlorothiazide who experience new or worsening shortness of breath should be promptly evaluated. Early diagnosis and discontinuation of the drug are crucial for preventing serious complications.

The report doesn’t suggest avoiding hydrochlorothiazide altogether, given its effectiveness in managing hypertension. However, it advocates for careful monitoring of patients and a high index of suspicion for drug-induced pulmonary edema, especially in those with unexplained respiratory symptoms.

Q: What should patients taking hydrochlorothiazide watch for? A: Patients should immediately report any new or worsening shortness of breath, cough, or difficulty breathing to their healthcare provider, as these could be signs of hydrochlorothiazide-induced pulmonary edema.

Frequently Asked Questions

  • What is pulmonary edema? Pulmonary edema is a condition caused by excess fluid in the lungs, making it difficult to breathe.
  • Is hydrochlorothiazide safe? Hydrochlorothiazide is generally safe and effective, but, like all medications, it can have rare side effects.
  • What should I do if I experience shortness of breath while taking hydrochlorothiazide? Seek immediate medical attention.

Further research is needed to better understand the mechanisms underlying hydrochlorothiazide-induced pulmonary edema and to identify individuals who may be at increased risk. In the meantime, clinicians should remain vigilant and consider this rare but potentially serious complication in their differential diagnosis.

Share your thoughts on this rare drug reaction in the comments below.



Leave a Comment